125 related articles for article (PubMed ID: 34993530)
1. Identification and optimization of tunable endosomal escape parameters for enhanced efficacy in peptide-targeted prodrug-loaded nanoparticles.
Mejia F; Khan S; Omstead DT; Minetos C; Bilgicer B
Nanoscale; 2022 Jan; 14(4):1226-1240. PubMed ID: 34993530
[TBL] [Abstract][Full Text] [Related]
2. Liposomal Targeting Modifies Endosomal Escape: Design and Mechanistic Implications.
Mejia F; Khan S; Bilgicer B
ACS Biomater Sci Eng; 2022 Mar; 8(3):1067-1073. PubMed ID: 35171570
[TBL] [Abstract][Full Text] [Related]
3. Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy.
Kim B; Shin J; Wu J; Omstead DT; Kiziltepe T; Littlepage LE; Bilgicer B
J Control Release; 2020 Jun; 322():530-541. PubMed ID: 32276005
[TBL] [Abstract][Full Text] [Related]
4. Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles.
Ahmad A; Khan JM; Haque S
Biochimie; 2019 May; 160():61-75. PubMed ID: 30797879
[TBL] [Abstract][Full Text] [Related]
5. Disease-driven engineering of peptide-targeted DM1 loaded liposomal nanoparticles for enhanced efficacy in treating multiple myeloma by exploring DM1 prodrug chemistry.
Khan S; Mejia F; Shin J; Hwang G; Omstead DT; Wu J; Cole SL; Littlepage LE; Bilgicer B
Biomaterials; 2023 Jan; 292():121913. PubMed ID: 36442437
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of Endosomolytic Peptides with Varying Disruption Mechanisms into EGFR-Targeted Protein Conjugates: The Effect on Intracellular Protein Delivery and EGFR Specificity in Breast Cancer Cells.
Lieser RM; Li Q; Chen W; Sullivan MO
Mol Pharm; 2022 Feb; 19(2):661-673. PubMed ID: 35040326
[TBL] [Abstract][Full Text] [Related]
7. Acid-responsive endosomolytic polymeric nanoparticles with amplification of intracellular oxidative stress for prodrug delivery and activation.
Lu N; Xi L; Zha Z; Wang Y; Han X; Ge Z
Biomater Sci; 2021 Jun; 9(13):4613-4629. PubMed ID: 34190224
[TBL] [Abstract][Full Text] [Related]
8. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
Wang W; Xi M; Duan X; Wang Y; Kong F
Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers.
Grosse SM; Tagalakis AD; Mustapa MF; Elbs M; Meng QH; Mohammadi A; Tabor AB; Hailes HC; Hart SL
FASEB J; 2010 Jul; 24(7):2301-13. PubMed ID: 20203088
[TBL] [Abstract][Full Text] [Related]
10. Chitosan Nanoparticles for Nuclear Targeting: The Effect of Nanoparticle Size and Nuclear Localization Sequence Density.
Tammam SN; Azzazy HM; Breitinger HG; Lamprecht A
Mol Pharm; 2015 Dec; 12(12):4277-89. PubMed ID: 26465978
[TBL] [Abstract][Full Text] [Related]
11. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D
Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203
[TBL] [Abstract][Full Text] [Related]
12. Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier.
Gou Y; Zhang Y; Zhang Z; Wang J; Zhou Z; Liang H; Yang F
Mol Pharm; 2017 Jun; 14(6):1861-1873. PubMed ID: 28471669
[TBL] [Abstract][Full Text] [Related]
13. Advancing Bone-Targeted Drug Delivery: Leveraging Biological Factors and Nanoparticle Designs to Improve Therapeutic Efficacy.
Xiao B; Ackun-Farmmer MA; Adjei-Sowah E; Liu Y; Chandrasiri I; Benoit DSW
ACS Biomater Sci Eng; 2024 Apr; 10(4):2224-2234. PubMed ID: 38537162
[TBL] [Abstract][Full Text] [Related]
14. Probing Endosomal Escape Using pHlexi Nanoparticles.
Kongkatigumjorn N; Cortez-Jugo C; Czuba E; Wong AS; Hodgetts RY; Johnston AP; Such GK
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27786422
[TBL] [Abstract][Full Text] [Related]
15. Reduction-Responsive Polymer Prodrug Micelles with Enhanced Endosomal Escape Capability for Efficient Intracellular Translocation and Drug Release.
Ibrahim A; Twizeyimana E; Lu N; Ke W; Mukerabigwi JF; Mohammed F; Japir AAMM; Ge Z
ACS Appl Bio Mater; 2019 Nov; 2(11):5099-5109. PubMed ID: 35021452
[TBL] [Abstract][Full Text] [Related]
16. Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.
Xu Y; Zheng Y; Wu L; Zhu X; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(11):9315-9324. PubMed ID: 29484890
[TBL] [Abstract][Full Text] [Related]
17. Identification of a moderate affinity CD22 binding peptide and in vitro optimization of peptide-targeted nanoparticles for selective uptake by CD22+ B-cell malignancies.
Kim B; Shin J; Kiziltepe T; Bilgicer B
Nanoscale; 2020 Jun; 12(21):11672-11683. PubMed ID: 32436925
[TBL] [Abstract][Full Text] [Related]
18. Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells.
Yang Z; Tang W; Luo X; Zhang X; Zhang C; Li H; Gao D; Luo H; Jiang Q; Liu J
J Biomed Nanotechnol; 2015 Aug; 11(8):1401-17. PubMed ID: 26295141
[TBL] [Abstract][Full Text] [Related]
19. Bispecific Antibodies for Targeted Delivery of Dendritic Polyglycerol (dPG) Prodrug Conjugates.
Mehrabadi FS; Adelmann J; Gupta S; Wedepohl S; Calderón M; Brinkmann U; Haag R
Curr Cancer Drug Targets; 2016; 16(7):639-49. PubMed ID: 26853135
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive cationic liposome for endosomal escape mediated drug delivery.
Rayamajhi S; Marchitto J; Nguyen TDT; Marasini R; Celia C; Aryal S
Colloids Surf B Biointerfaces; 2020 Apr; 188():110804. PubMed ID: 31972443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
